Full investment portfolio of the Relevant Investments as at 31 December 2021
| Relevant Investment | Type | Primary Listing | Country of Issuer | Currency | Total Cost | Mark-to-market Value | Weighting of GAV *(%) | Credit Rating (S&P's/Moody's/Fitch's) |
| NANFUN 4 ½ 09/20/22 EMTN | Bond | Singapore Exchange | BVI | USD | HK$9,797,000 | HK$9,517,000 | 0.0140% | BBB- / Baa3 / - |
| NANFUN 4 ⅞ 05/29/24 EMTN | Bond | Singapore Exchange | BVI | USD | HK$56,602,000 | HK$56,262,000 | 0.0827% | BBB- / Baa3 / - |
| HKTGHD 3 ¾ 03/08/23 | Bond | Singapore Exchange | BVI | USD | HK$49,641,000 | HK$50,496,000 | 0.0742% | BBB / Baa2 / - |
| CAPG 6.35 02/08/24 | Bond | Singapore Exchange | Cayman Islands | USD | HK$38,747,000 | HK$6,979,000 | 0.0103% | - / Caa3 / C |
| MOLAND 11 ½ 11/13/22 | Bond | Singapore Exchange | Cayman Islands | USD | HK$3,809,000 | HK$1,210,000 | 0.0018% | - / - / C |
| CIFIHG 5.95 10/20/25 | Bond | Hong Kong Exchange | Cayman Islands | USD | HK$61,991,000 | HK$60,941,000 | 0.0896% | BB- / - / BB |
| CAPG 4.2 01/20/22 | Bond | Singapore Exchange | Cayman Islands | USD | HK$29,945,000 | HK$6,145,000 | 0.0090% | - / - / - |
| EC Healthcare (Stock Code: 2138.HK) | Equity | Hong Kong Exchange | Cayman Islands | HKD | HK$51,810,000 | HK$136,814,000 | 0.2011% | N/A |
| Total | HK$302,342,000 | HK$328,364,000 | 0.4827% | |||||